Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions

Prostatic Neoplasms

Interventions

DIETARY_SUPPLEMENT

PectaSol-C Modified Citrus Pectin (MCP)

Oral administration of PectaSol-C MCP (4.8 grams in six capsules three times a day away from food).

Trial Locations (1)

Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center, Tshernichovsky 59,, Kfar Saba